Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial.

Billings, Liana K; Doshi, Ankur; Gouet, Didier; Oviedo, Alejandra; Rodbard, Helena W; Tentolouris, Nikolaos; Grøn, Randi; Halladin, Natalie; Jodar, Esteban

Billings, Liana K; Doshi, Ankur; Gouet, Didier; Oviedo, Alejandra; Rodbard, Helena W; Tentolouris, Nikolaos; Grøn, Randi; Halladin, Natalie; Jodar, Esteban.

Affiliation

Billings LK; NorthShore University HealthSystem, Evanston, IL lbillings@northshore.org.
Doshi A; University of Chicago Pritzker School of Medicine, Chicago, IL.
Gouet D; PrimeCare Medical Group, Houston, TX.
Oviedo A; La Rochelle Hospital, La Rochelle, France.
Rodbard HW; Santojanni Hospital and Cenudiab, Ciudad Autonoma de Buenos Aires, Argentina.
Tentolouris N; Endocrine and Metabolic Consultants, Rockville, MD.
Grøn R; Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Halladin N; Novo Nordisk A/S, Søborg, Denmark.
Jodar E; Novo Nordisk A/S, Søborg, Denmark.

Diabetes Care ; 41(5): 1009-1016, 2018 05.

Article in En | MEDLINE | ID: mdl-29483185

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Insulin, Long-Acting / Diabetes Mellitus, Type 2 / Liraglutide / Hypoglycemic Agents / Insulin / Metformin Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Care Year: 2018 Document type: Article Affiliation country: Israel

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google